Literature DB >> 3724737

Spirochetal diseases of the CNS.

A R Pachner.   

Abstract

The neurotropism of the spirochete is evident from the above discussions of syphilis, Lyme disease, leptospirosis, and relapsing fever. In all of these diseases, the organism very likely enters the CNS very early in the course of the disease. The fate of the organism then depends on the virulence of the spirochete, the host defenses, and any antibiotic treatment administered. Why Treponema pallidum lays dormant in the CNS and then somehow reactivates is a mystery; the same mystery occurs in Lyme disease. Leptospirosis and relapsing fever seem to be infections much more limited in time, and are not reported to cause these long-term sequelae. The treatment of these last two infections seems to be fairly straightforward. However, the appropriate treatment for the various stages of the disease in both syphilis and Lyme disease in order to prevent long-term sequelae is not universally accepted. At this time, it seems that high-dose intravenous penicillin is the treatment of choice for each of these infections shown to be active in the nervous system.

Entities:  

Mesh:

Year:  1986        PMID: 3724737

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  5 in total

Review 1.  Lyme disease.

Authors:  D W Rahn; S E Malawista
Journal:  West J Med       Date:  1991-06

2.  Immunologic and genetic analyses of VmpA of a neurotropic strain of Borrelia turicatae.

Authors:  D Cadavid; P M Pennington; T A Kerentseva; S Bergström; A G Barbour
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  Borrelia burgdorferi infection in Europe: an HLA-related disease?

Authors:  C D Reimers; U Neubert; W Kristoferitsch; K H Pflüger; W R Mayr
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

Review 4.  Current recommendations for the treatment of Lyme disease.

Authors:  L H Sigal
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

Review 5.  Neuropsychological functioning in chronic Lyme disease.

Authors:  Holly James Westervelt; Robert J McCaffrey
Journal:  Neuropsychol Rev       Date:  2002-09       Impact factor: 6.940

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.